| UniProt ID | H2AW_HUMAN | |
|---|---|---|
| UniProt AC | Q9P0M6 | |
| Protein Name | Core histone macro-H2A.2 | |
| Gene Name | H2AFY2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 372 | |
| Subcellular Localization | Nucleus . Chromosome . Enriched in inactive X chromosome chromatin (PubMed:11331621, PubMed:11262398) and in senescence-associated heterochromatin (PubMed:15621527). | |
| Protein Description | Variant histone H2A which replaces conventional H2A in a subset of nucleosomes where it represses transcription. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. May be involved in stable X chromosome inactivation.. | |
| Protein Sequence | MSGRSGKKKMSKLSRSARAGVIFPVGRLMRYLKKGTFKYRISVGAPVYMAAVIEYLAAEILELAGNAARDNKKARIAPRHILLAVANDEELNQLLKGVTIASGGVLPRIHPELLAKKRGTKGKSETILSPPPEKRGRKATSGKKGGKKSKAAKPRTSKKSKPKDSDKEGTSNSTSEDGPGDGFTILSSKSLVLGQKLSLTQSDISHIGSMRVEGIVHPTTAEIDLKEDIGKALEKAGGKEFLETVKELRKSQGPLEVAEAAVSQSSGLAAKFVIHCHIPQWGSDKCEEQLEETIKNCLSAAEDKKLKSVAFPPFPSGRNCFPKQTAAQVTLKAISAHFDDSSASSLKNVYFLLFDSESIGIYVQEMAKLDAK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | O-linked_Glycosylation | ------MSGRSGKKK ------CCCCCCHHH | 42.80 | 30379171 | |
| 7 | Lactoylation | -MSGRSGKKKMSKLS -CCCCCCHHHHHHHH | 50.93 | - | |
| 9 | Lactoylation | SGRSGKKKMSKLSRS CCCCCHHHHHHHHHH | 52.47 | - | |
| 12 | Acetylation | SGKKKMSKLSRSARA CCHHHHHHHHHHHHC | 47.16 | 19608861 | |
| 27 | Methylation | GVIFPVGRLMRYLKK CEEEEHHHHHHHHHH | 26.08 | - | |
| 31 | Phosphorylation | PVGRLMRYLKKGTFK EHHHHHHHHHHCCEE | 14.65 | - | |
| 55 | Phosphorylation | YMAAVIEYLAAEILE HHHHHHHHHHHHHHH | 7.19 | - | |
| 102 | Phosphorylation | LKGVTIASGGVLPRI HHCCEECCCCCCCCC | 32.03 | 24114839 | |
| 116 | Ubiquitination | IHPELLAKKRGTKGK CCHHHHHHHCCCCCC | 42.86 | 21906983 | |
| 117 | Ubiquitination | HPELLAKKRGTKGKS CHHHHHHHCCCCCCC | 50.91 | - | |
| 120 | Phosphorylation | LLAKKRGTKGKSETI HHHHHCCCCCCCCCC | 40.43 | 29038488 | |
| 123 | Ubiquitination | KKRGTKGKSETILSP HHCCCCCCCCCCCCC | 46.83 | 21906983 | |
| 124 | Phosphorylation | KRGTKGKSETILSPP HCCCCCCCCCCCCCC | 48.95 | 26330541 | |
| 126 | Phosphorylation | GTKGKSETILSPPPE CCCCCCCCCCCCCCH | 34.02 | 30266825 | |
| 129 | Phosphorylation | GKSETILSPPPEKRG CCCCCCCCCCCHHCC | 31.35 | 30266825 | |
| 140 | Phosphorylation | EKRGRKATSGKKGGK HHCCCCCCCCCCCCC | 40.84 | 20860994 | |
| 160 | Phosphorylation | KPRTSKKSKPKDSDK CCCCCCCCCCCCCCC | 58.91 | - | |
| 165 | Phosphorylation | KKSKPKDSDKEGTSN CCCCCCCCCCCCCCC | 57.62 | 28450419 | |
| 170 | Phosphorylation | KDSDKEGTSNSTSED CCCCCCCCCCCCCCC | 26.31 | 28450419 | |
| 171 | Phosphorylation | DSDKEGTSNSTSEDG CCCCCCCCCCCCCCC | 39.37 | 28450419 | |
| 173 | Phosphorylation | DKEGTSNSTSEDGPG CCCCCCCCCCCCCCC | 32.83 | 26657352 | |
| 174 | Phosphorylation | KEGTSNSTSEDGPGD CCCCCCCCCCCCCCC | 40.15 | 26657352 | |
| 175 | Phosphorylation | EGTSNSTSEDGPGDG CCCCCCCCCCCCCCC | 33.25 | 28450419 | |
| 190 | Phosphorylation | FTILSSKSLVLGQKL EEEEECCCEECCCCE | 26.17 | 27251275 | |
| 198 | Phosphorylation | LVLGQKLSLTQSDIS EECCCCEECCHHHHH | 36.08 | 22817900 | |
| 200 | Phosphorylation | LGQKLSLTQSDISHI CCCCEECCHHHHHHH | 23.74 | 22817900 | |
| 205 | Phosphorylation | SLTQSDISHIGSMRV ECCHHHHHHHHCCEE | 17.65 | 20860994 | |
| 239 | Sumoylation | ALEKAGGKEFLETVK HHHHCCCHHHHHHHH | 44.36 | 28112733 | |
| 239 | Ubiquitination | ALEKAGGKEFLETVK HHHHCCCHHHHHHHH | 44.36 | - | |
| 246 | Ubiquitination | KEFLETVKELRKSQG HHHHHHHHHHHHCCC | 59.45 | 21906983 | |
| 251 | Phosphorylation | TVKELRKSQGPLEVA HHHHHHHCCCCHHHH | 33.66 | 27050516 | |
| 263 | Phosphorylation | EVAEAAVSQSSGLAA HHHHHHHHCCCCCHH | 21.44 | - | |
| 266 | Phosphorylation | EAAVSQSSGLAAKFV HHHHHCCCCCHHHEE | 30.13 | - | |
| 285 | Acetylation | IPQWGSDKCEEQLEE CCCCCCHHHHHHHHH | 45.29 | 25825284 | |
| 304 | Acetylation | CLSAAEDKKLKSVAF HHHHHHHHCCCCCCC | 52.06 | 25825284 | |
| 332 | Ubiquitination | TAAQVTLKAISAHFD CHHHHHHHHHHHCCC | 34.02 | 21906983 | |
| 341 | Phosphorylation | ISAHFDDSSASSLKN HHHCCCCCCCHHHCC | 29.64 | 27251275 | |
| 342 | Phosphorylation | SAHFDDSSASSLKNV HHCCCCCCCHHHCCE | 38.88 | 25849741 | |
| 362 | Phosphorylation | DSESIGIYVQEMAKL CHHHHEEHHHHHHHH | 7.29 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of H2AW_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of H2AW_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of H2AW_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-12, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129, AND MASSSPECTROMETRY. | |